Investegate |Covis Pharma Announcements | Covis Pharma: Covis Pharma Announces Positive Topline Results from the AVANT Phase 3 Clinical Trial Showing Significant Improvement in Patients with Moderate to Severe Stable COPD
Investegate announcements from Covis Pharma, Covis Pharma Announces Positive Topline Results from the AVANT Phase 3 Clinical Trial Showing Significant Improvement in Patients with Moderate to Severe Stable COPD
Republic Of Covis Pharma Covis Pharma Group Drug Administration Covis Pharma Announces Positive Topline Results Trial Showing Significant Improvement
Source: investegate.co.uk